In this issue

Issue 117 • March 2022

Two years after the World Health Organization (WHO) declared the pandemic that is Covid-19, we look back on the fallout in terms of the learning lessons for vaccine supply chains. Writer Darcy Jimenez explores the value of strategic partnerships to the importance of localised manufacturing when it comes to the delivery of other essential vaccines.

Also in this issue, we look at the impact of Covid-19 on the already stretched chimeric antigen receptor (CAR)-T cell therapy industry. Writer Adam Zamecnik reports how in addition to the demand for viral vectors, shortages of other important materials like plastics that are part of production has had an impact. Despite improvements in the industry, the pandemic continues to affect the sector’s development.

Elsewhere, we explore the impact of Russian sanctions on the Sputnik Covid-19 vaccine production, find out how NFTs could democratise access to health information, consider distribution challenges for rare disease drugs, and more.

Read on for all this, as well as the latest pharma industry comment, data and analysis from GlobalData.

Jennifer C. Smith-Parker, editor

Go to article: Home | Two years of Covid-19Go to article: In this issueGo to article: ContentsGo to article: Mimotopes Company Insight Go to article: MimotopesGo to article: CSafe GlobalGo to article: BriefingGo to article: Industry newsGo to article: The pharma industry briefingGo to article: Covid-19 executive briefing by GlobalDataGo to article: Controlant Company InsightGo to article: ControlantGo to article: Contract Pharmaceuticals Limited CanadaGo to article: CommentGo to article: Ukraine: Russian invasion could cause spike in Covid-19 cases Go to article: First vaccines, now drugs: FDA’s second wave of emergency Covid-19 approvalsGo to article: International Women’s Day spotlight: endometriosisGo to article: Remote audits – stopgap measure or the new normal?Go to article: Owen Mumford Company Insight Go to article: Owen MumfordGo to article: BaxterGo to article: In DepthGo to article: Two years of Covid-19: lessons the pandemic taught about delivering essential vaccinesGo to article: A perfect storm: Covid-19 viral vector manufacturing adds further burden to CAR-Go to article: Russia sanctions: what next for Sputnik Covid-19 vaccine production around the wGo to article: Profit for patients: can NFTs allow people to monetise their health data?Go to article: Navigating distribution challenges for rare disease drugsGo to article: NiproGo to article: Datwyler Company InsightGo to article: DatwylerGo to article: In DataGo to article: North America is seeing a hiring boom in pharma digital media rolesGo to article: Filings buzz: 23% increase in industrial automation mentions in Q3 of 2021Go to article: Event: Outsourcing in Clinical Trials Europe 2022Go to article: EventsGo to article: Next issue